Product Description
iCare Hiv 1&2 Rapid Test Kits – For Home / Field Use |
The assay starts with a sample applied to the sample well. A recombinant HIV antigen conjugated to colloidal gold embedded in the sample pad reacts with the HIV antibody present in whole blood, serum or plasma forming conjugate/HIV antibody complex. As the mixture is allowed to migrate along the test strip, the conjugate/HIV antibody complex is captured by recombinant HIV antigen immobilized on a membrane forming a colored test line in the test region. A negative sample does not produce a test line due to the absence of colloidal gold conjugate/HIV antibody complex. The antigens used in the conjugate test are recombinant proteins that correspond to highly immunoreactive regions of HIV1 and HIV2. A colored control line in the control region appears at the end of test procedure regardless of test result. This control line is the result of colloidal gold conjugate binding to the anti-HIV antibody immobilized on the membrane. The control line indicates that the colloidal gold conjugate is functional.
Two test lines are coated on the membrane; on T1 region recombinant gp41, p24, and gp120 are immobilized; most of HIV I or HIV II infected samples give positive results on T1 region; On T2 region a recombinant gp36 is coated, which is HIV II specific, and a positive result appearing on T2 region indicates a HIVⅡ positive samples.
The ICARE Anti-HIV(1&2) Tri-line Test is a immunochromatographic (rapid) test for the qualitative detection of antibodies of all isotypes (IgG,IgM,IgA) specific to HIV-1 including subtype O and HIV-2 simultaneously, in human whole blood, serum or plasma.
- Packing: Hospital Version: 40T
- Field Version: 1T per box
- Specimen: Whole blood / Serum / Plasma
- Type of Test: Antibody
- Format: Hospital Version: 1 well cassette, pipette, diluents ( 6 bottles)
- Field Version: 1 well cassette, pipette
- Sample: 10μL serum
- Specificity: 100.0%
- Sensitivity: 99.0%
- Shelf Life: 24 months
- Certifications: WHO/USAID/NICD (S Africa) / various independent lab evaluation from Maryland (USA), UK, Mexico, Uganda, Malaysia & China
System Specification
iCARE HIV (1 & 2) Rapid Screen Test Specifications: |
Category Name | STD Rapid Test Kit |
Catalog No | IT1002 |
Packing | Hospital Version: 40T Field Version: 1T |
Specimen | Whole blood / Serum / Plasma |
Type of Test | Antibody |
Format | Hospital version: 1 well cassette, pipette, diluents (6 bottles Field version: 1 well cassette, pipette |
Sample | 10ul serum |
Result | Within 15 minutes |
Specificity | 100% |
Sensitivity | 100% |
Shelf Life | 24 months |
Storage | Store at 4 ºC ~ 30 ºC in the sealed pouch up to the expiration date. |
Company Information
JAL Innovation Singapore’s goal is to serve our global partners with a truly integrated biomedical manufacturing facility by offering a wide range of advanced rapid in-vitro immunodiagnostic test systems and electrical bio sensing systems, particularly blood glucose monitoring systems for home and professional use. We are committed to serve our partners by manufacturing and distributing high quality, reliable and competitive products and services to every continent. Our vision is to provide safe, reliable and cost effective solutions in markets around the world.
Our range of products include our in-house brand and iCARE private label brand of diabetic monitoring systems and also the iCARE range of in-vitro diagnostic testing kits, particularly for infectious and sexually transmitted diseases. Our iCare brand of products cover Health Screening, Infectious Diseases, Fertility, Chronic & Critical Illnesses, Alcohol and Drugs of Abuse. We specialize in a range of iCARE blood glucose monitoring systems for capillary blood and alternate site testing to meet every demand of the market.
JAL Innovation production facilities are ISO 13485 and GMP certified.
Copyright © 2015. JAL INNOVATION (S) PTE. LTD. All Rights Reserved | Product Ranking Service by Opal Infotech |
---|